AI coding tools like Claude Code and Cursor boast 80-90% initial code acceptance rates, but real-world effectiveness collapses to just 10-30% after required revisions, with AI users generating 9.4x more code churn and heavy token users achieving only 2x throughput at 10x the cost — yet adoption continues accelerating despite …
A security researcher uses Anthropic's Claude Opus 4.6 to build a fully working Chrome exploit for just $2,283, sparking urgent warnings that AI is dangerously compressing the time between patch releases and active cyberattacks.
A2UI v0.9 launches as a groundbreaking framework-agnostic standard, empowering AI agents to generate real-time, tailored UI widgets across web and mobile platforms, with major adoptions already underway from industry giants including Vercel, Oracle, AG2, and AG-UI.
Anthropic releases Claude Opus 4.7, its most powerful coding and agentic model yet, featuring adaptive reasoning that dynamically allocates thinking resources, a new 'xhigh' effort tier, and smarter bug detection — but users must adjust prompting habits as the model defaults to leaner, less verbose responses than its predecessor.
OpenAI doubles its deal with AI chipmaker Cerebras to over $20 billion, takes a potential 10% minority stake, and invests $1 billion in data center development, as Cerebras eyes a $35 billion IPO in Q2 2025.
Alibaba launches Qwen3.6, a powerful new AI model boasting advanced agentic coding, multimodal capabilities, and support for 201 languages, now available on Hugging Face Hub under an open Apache 2.0 license.
DeepL launches a voice-to-voice translation suite targeting meetings, mobile, and frontline workers, with plans to develop an end-to-end voice model that eliminates the text conversion step entirely, entering a competitive market against rivals like Sanas, Camb.AI, and Palabra.
Roblox supercharges its AI Assistant with agentic Planning Mode, automated playtesting, and new 3D mesh generation tools, creating a self-correcting development loop that helps creators build, test, and debug games faster than ever.
OpenAI launches GPT-Rosalind, a restricted life sciences AI model that outperforms 95% of human experts in RNA sequence prediction and surpasses other AI on science benchmarks, with access limited to approved organizations like Amgen and Moderna due to misuse concerns.
OpenAI launches GPT-Rosalind, a frontier AI model purpose-built for life sciences that outperforms human experts above the 95th percentile on RNA sequence-to-function tasks, beats competitors on key benchmarks, and is now available in research preview for U.S. Enterprise customers through partnerships with Amgen, Moderna, and the Allen Institute.